{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:46Z","timestamp":1790289106321,"version":"4.1.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s40264-017-0629-8","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T03:31:02Z","timestamp":1517887862000},"page":"451-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Drug-Induced Ototoxicity: Diagnosis and Monitoring"],"prefix":"10.1007","volume":"41","author":[{"given":"Kathleen C. M.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen G.","family":"Le Prell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"issue":"11","key":"629_CR1","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ar.22578","volume":"295","author":"J Schacht","year":"2012","unstructured":"Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec. 2012;295(11):1837\u201350.","journal-title":"Anat Rec."},{"issue":"1","key":"629_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000013861","volume":"5","author":"A Forge","year":"2000","unstructured":"Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol. 2000;5(1):3\u201322.","journal-title":"Audiol Neurootol."},{"key":"629_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/14992027.2017.1381769","author":"AC Garinis","year":"2017","unstructured":"Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D. Ototoxicity monitoring through the eyes of the treating physician: perspectives from pulmonology and medical oncology. Int J Audiol. 2017. https:\/\/doi.org\/10.1080\/14992027.2017.1381769 (Epub 5 Oct 2017).","journal-title":"Int J Audiol."},{"issue":"7","key":"629_CR4","first-page":"594","volume":"58","author":"CH Clark","year":"1977","unstructured":"Clark CH. Toxicity of aminoglycoside antibiotics. Mod Vet Pract. 1977;58(7):594\u20138.","journal-title":"Mod Vet Pract."},{"issue":"1\u20132","key":"629_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.heares.2011.05.008","volume":"281","author":"J Xie","year":"2011","unstructured":"Xie J, Talaska AE, Schacht J. New developments in aminoglycoside therapy and ototoxicity. Hear Res. 2011;281(1\u20132):28\u201337.","journal-title":"Hear Res."},{"issue":"11","key":"629_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.5694\/mja11.10850","volume":"196","author":"RM Ahmed","year":"2012","unstructured":"Ahmed RM, Hannigan IP, MacDougall HG, Chan RC, Halmagyi GM. Gentamicin ototoxicity: a 23-year selected case series of 103 patients. Med J Aust. 2012;196(11):701\u20134.","journal-title":"Med J Aust."},{"issue":"2","key":"629_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1128\/AAC.12.2.178","volume":"12","author":"EF Christensen","year":"1977","unstructured":"Christensen EF, Reiffenstein JC, Madissoo H. Comparative ototoxicity of amikacin and gentamicin in cats. Antimicrob Agents Chemother. 1977;12(2):178\u201384.","journal-title":"Antimicrob Agents Chemother."},{"issue":"6","key":"629_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/rccm.200109-012CC","volume":"167","author":"KH Tan","year":"2003","unstructured":"Tan KH, Mulheran M, Knox AJ, Smyth AR. Aminoglycoside prescribing and surveillance in cystic fibrosis. Am J Respir Crit Care Med. 2003;167(6):819\u201323.","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"629_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0385-8146(04)00147-6","volume":"31","author":"T Kusunoki","year":"2004","unstructured":"Kusunoki T, Cureoglu S, Schachern PA, Sampaio A, Fukushima H, Oktay MF, et al. Effects of aminoglycoside administration on cochlear elements in human temporal bones. Auris Nasus Larynx. 2004;31(4):383\u20138.","journal-title":"Auris Nasus Larynx."},{"issue":"10","key":"629_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/00005537-200110000-00025","volume":"111","author":"R Hinojosa","year":"2001","unstructured":"Hinojosa R, Nelson EG, Lerner SA, Redleaf MI, Schramm DR. Aminoglycoside ototoxicity: a human temporal bone study. Laryngoscope. 2001;111(10):1797\u2013805.","journal-title":"Laryngoscope."},{"key":"629_CR11","first-page":"1","volume":"383","author":"LG Johnsson","year":"1981","unstructured":"Johnsson LG, Hawkins JE Jr, Kingsley TC, Black FO, Matz GJ. Aminoglycoside-induced cochlear pathology in man. Acta Otolaryngol Suppl (Stockh). 1981;383:1\u201319.","journal-title":"Acta Otolaryngol Suppl (Stockh)."},{"issue":"3","key":"629_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0196-0709(84)80009-5","volume":"5","author":"SA Fausti","year":"1984","unstructured":"Fausti SA, Rappaport BZ, Schechter MA, Frey RH, Ward TT, Brummett RE. Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies. Am J Otolaryngol. 1984;5(3):177\u201382.","journal-title":"Am J Otolaryngol."},{"issue":"6","key":"629_CR13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","volume":"165","author":"SA Fausti","year":"1992","unstructured":"Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis. 1992;165(6):1026\u201332.","journal-title":"J Infect Dis."},{"issue":"1","key":"629_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0196-0709(79)80004-6","volume":"1","author":"WC Stebbins","year":"1979","unstructured":"Stebbins WC, Hawkins JE Jr, Johnson LG, Moody DB. Hearing thresholds with outer and inner hair cell loss. Am J Otolaryngol. 1979;1(1):15\u201327.","journal-title":"Am J Otolaryngol."},{"issue":"4","key":"629_CR15","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1183\/09031936.00184312","volume":"42","author":"V Melchionda","year":"2013","unstructured":"Melchionda V, Wyatt H, Capocci S, Garcia Medina R, Solamalai A, Katiri S, et al. Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required? Eur Respir J. 2013;42(4):1148\u201350.","journal-title":"Eur Respir J."},{"issue":"9","key":"629_CR16","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","volume":"45","author":"M Mulheran","year":"2001","unstructured":"Mulheran M, Degg C, Burr S, Morgan DW, Stableforth DE. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy. Antimicrob Agents Chemother. 2001;45(9):2502\u20139.","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"629_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/00365548.2012.747694","volume":"45","author":"H Hanberger","year":"2013","unstructured":"Hanberger H, Edlund C, Furebring M, Giske G, Melhus A, Nilsson LE, et al. Rational use of aminoglycosides\u2014review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). Scand J Infect Dis. 2013;45(3):161\u201375.","journal-title":"Scand J Infect Dis."},{"issue":"5","key":"629_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0025-6196(11)65134-3","volume":"74","author":"RS Edson","year":"1999","unstructured":"Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc. 1999;74(5):519\u201328.","journal-title":"Mayo Clin Proc."},{"issue":"5","key":"629_CR19","doi-asserted-by":"publisher","first-page":"e64915","DOI":"10.1371\/journal.pone.0064915","volume":"8","author":"J Gao","year":"2013","unstructured":"Gao J, Zheng P, Fu H. Prevalence of TB\/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One. 2013;8(5):e64915.","journal-title":"PLoS One."},{"issue":"3","key":"629_CR20","first-page":"400","volume":"19","author":"JZ Metcalfe","year":"2013","unstructured":"Metcalfe JZ, Porco TC, Westenhouse J, Damesyn M, Facer M, Hill J, et al. Tuberculosis and HIV co-infection, California, USA, 1993\u20132008. Emerg Infect Dis. 2013;19(3):400\u20136.","journal-title":"Emerg Infect Dis."},{"issue":"1","key":"629_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11908-012-0311-3","volume":"15","author":"GM Varghese","year":"2013","unstructured":"Varghese GM, Janardhanan J, Ralph R, Abraham OC. The twin epidemics of tuberculosis and HIV. Curr Infect Dis Rep. 2013;15(1):77\u201384.","journal-title":"Curr Infect Dis Rep."},{"issue":"1","key":"629_CR22","first-page":"37","volume":"23","author":"L Horgen","year":"1999","unstructured":"Horgen L, Legrand E, Rastogi N. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium. FEMS Immunol Med Microbiol. 1999;23(1):37\u201344.","journal-title":"FEMS Immunol Med Microbiol."},{"issue":"5","key":"629_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1055\/s-0028-1085708","volume":"29","author":"SH Kasperbauer","year":"2008","unstructured":"Kasperbauer SH, Daley CL. Diagnosis and treatment of infections due to Mycobacterium avium complex. Sem Respir Crit Care Med. 2008;29(5):569\u201376.","journal-title":"Sem Respir Crit Care Med."},{"issue":"6","key":"629_CR24","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3349\/ymj.2010.51.6.888","volume":"51","author":"YS Sim","year":"2010","unstructured":"Sim YS, Park HY, Jeon K, Suh GY, Kwon OJ, Koh WJ. Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Med J. 2010;51(6):888\u201394.","journal-title":"Yonsei Med J."},{"issue":"1","key":"629_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12879-017-2665-5","volume":"17","author":"K Yagi","year":"2017","unstructured":"Yagi K, Ishii M, Namkoong H, Asami T, Iketani O, Asakura T, et al. The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases. BMC Infect Dis. 2017;17(1):558.","journal-title":"BMC Infect Dis."},{"issue":"1","key":"629_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.4125","volume":"26","author":"EL Sagwa","year":"2017","unstructured":"Sagwa EL, Souverein PC, Ribeiro I, Leufkens HG, Mantel-Teeuwisse AK. Differences in VigiBase(R) reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment. Pharmacoepidemiol Drug Saf. 2017;26(1):1\u20138.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"629_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40360-015-0036-7","volume":"16","author":"EL Sagwa","year":"2015","unstructured":"Sagwa EL, Ruswa N, Mavhunga F, Rennie T, Leufkens HG, Mantel-Teeuwisse AK. Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort. BMC Pharmacol Toxicol. 2015;16:36.","journal-title":"BMC Pharmacol Toxicol."},{"issue":"8","key":"629_CR28","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/jac\/dkr221","volume":"66","author":"A Sturdy","year":"2011","unstructured":"Sturdy A, Goodman A, Jose RJ, Loyse A, O\u2019Donoghue M, Kon OM, et al. Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother. 2011;66(8):1815\u201320.","journal-title":"J Antimicrob Chemother."},{"issue":"5","key":"629_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3766\/jaaa.21.5.3","volume":"21","author":"D Konrad-Martin","year":"2010","unstructured":"Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS, Bratt GW, et al. Evaluation of audiometric threshold shift criteria for ototoxicity monitoring. J Am Acad Audiol. 2010;21(5):301\u201314 (quiz 57).","journal-title":"J Am Acad Audiol."},{"issue":"5","key":"629_CR30","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S1808-8694(15)30120-8","volume":"73","author":"AM Silva da","year":"2007","unstructured":"da Silva AM, Latorre Mdo R, Cristofani LM, Odone Filho V. The prevalence of hearing loss in children and adolescents with cancer. Braz J Otorhinolaryngol. 2007;73(5):608\u201314.","journal-title":"Braz J Otorhinolaryngol."},{"issue":"4","key":"629_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1200\/JCO.2016.69.2319","volume":"35","author":"KR Knight","year":"2017","unstructured":"Knight KR, Chen L, Freyer D, Aplenc R, Bancroft M, Bliss B, et al. Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the children\u2019s oncology group. J Clin Oncol. 2017;35(4):440\u20135.","journal-title":"J Clin Oncol."},{"issue":"42","key":"629_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/1463-1741.45310","volume":"11","author":"H Li","year":"2009","unstructured":"Li H, Steyger PS. Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics. Noise Health. 2009;11(42):26\u201332.","journal-title":"Noise Health."},{"key":"629_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-319-13473-4_10","volume-title":"Oxidative stress in applied basic research and clinical practice: free radicals in ENT pathology","author":"LP Rybak","year":"2015","unstructured":"Rybak LP, Brenner MJ. Aminoglycoside-induced oxidative stress: pathways and protection. In: Miller JM, Le Prell CG, Rybak LP, editors. Oxidative stress in applied basic research and clinical practice: free radicals in ENT pathology. New York: Humana Press; 2015. p. 195\u2013216."},{"key":"629_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fncel.2017.00308","volume":"11","author":"M Jiang","year":"2017","unstructured":"Jiang M, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: A review. Front Cell Neurosci. 2017;11:308.","journal-title":"Front Cell Neurosci."},{"issue":"4","key":"629_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00129492-200407000-00025","volume":"25","author":"FO Black","year":"2004","unstructured":"Black FO, Pesznecker S, Stallings V. Permanent gentamicin vestibulotoxicity. Otol Neurotol. 2004;25(4):559\u201369.","journal-title":"Otol Neurotol."},{"key":"629_CR36","first-page":"185","volume":"209","author":"JL Esterhai Jr","year":"1986","unstructured":"Esterhai JL Jr, Bednar J, Kimmelman CP. Gentamicin-induced ototoxicity complicating treatment of chronic osteomyelitis. Clin Orthop Relat Res. 1986;209:185\u20138.","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"629_CR37","first-page":"256","volume":"93","author":"DD Kokong","year":"2014","unstructured":"Kokong DD, Bakari A, Ahmad BM. Ototoxicity in Nigeria: why it persists. Ear Nose Throat J. 2014;93(7):256\u201364.","journal-title":"Ear Nose Throat J."},{"issue":"10","key":"629_CR38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/INF.0b013e31821e405d","volume":"30","author":"EJ Best","year":"2011","unstructured":"Best EJ, Gazarian M, Cohn R, Wilkinson M, Palasanthiran P. Once-daily gentamicin in infants and children: a prospective cohort study evaluating safety and the role of therapeutic drug monitoring in minimizing toxicity. Pediatr Infect Dis J. 2011;30(10):827\u201332.","journal-title":"Pediatr Infect Dis J."},{"issue":"6","key":"629_CR39","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1651-2227.1989.tb11160.x","volume":"78","author":"H Colding","year":"1989","unstructured":"Colding H, Andersen EA, Prytz S, Wulffsberg H, Andersen GE. Auditory function after continuous infusion of gentamicin to high-risk newborns. Acta Paediatr Scand. 1989;78(6):840\u20133.","journal-title":"Acta Paediatr Scand."},{"issue":"4","key":"629_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000237791","volume":"24","author":"P Echeverria","year":"1978","unstructured":"Echeverria P, Fina D, Norton S, Smith AL. Ototoxicity of gentamicin: clinical experience in a children\u2019s hospital. Chemotherapy. 1978;24(4):267\u201371.","journal-title":"Chemotherapy."},{"issue":"6","key":"629_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1017\/S0022215100083985","volume":"91","author":"DA Moffat","year":"1977","unstructured":"Moffat DA, Ramsden RT. Profound bilateral sensorineural hearing loss during gentamicin therapy. J Laryngol Otol. 1977;91(6):511\u20136.","journal-title":"J Laryngol Otol."},{"issue":"6","key":"629_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF02961666","volume":"160","author":"D Mulherin","year":"1991","unstructured":"Mulherin D, Fahy J, Grant W, Keogan M, Kavanagh B, FitzGerald M. Aminoglycoside induced ototoxicity in patients with cystic fibrosis. Ir J Med Sci. 1991;160(6):173\u20135.","journal-title":"Ir J Med Sci."},{"issue":"8841","key":"629_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0140-6736(93)90137-6","volume":"341","author":"JM Prins","year":"1993","unstructured":"Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet. 1993;341(8841):335\u20139.","journal-title":"Lancet."},{"issue":"2","key":"629_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/infdis\/149.2.257","volume":"149","author":"OC Tablan","year":"1984","unstructured":"Tablan OC, Reyes MP, Rintelmann WF, Lerner AM. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. J Infect Dis. 1984;149(2):257\u201363.","journal-title":"J Infect Dis."},{"key":"629_CR45","unstructured":"Frymark T, Leech H, Mullen R, Schooling T, Venediktov R, Wang B. Evidence-based systematic review: drug-induced hearing loss\u2014gentamicin. American Speech-Language-Hearing Assocation (ASHA). Rockville, MD: National Center for Evidence-Based Practice in Communication Disorders; 2010. p. 1\u201320."},{"issue":"6","key":"629_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4103\/0300-1652.193861","volume":"57","author":"P Saleh","year":"2016","unstructured":"Saleh P, Abbasalizadeh S, Rezaeian S, Naghavi-Behzad M, Piri R, Pourfeizi HH. Gentamicin-mediated ototoxicity and nephrotoxicity: a clinical trial study. Niger Med J. 2016;57(6):347\u201352.","journal-title":"Niger Med J."},{"issue":"11","key":"629_CR47","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/pbc.24631","volume":"60","author":"KS Chen","year":"2013","unstructured":"Chen KS, Bach A, Shoup A, Winick NJ. Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides. Pediatr Blood Cancer. 2013;60(11):1772\u20137.","journal-title":"Pediatr Blood Cancer."},{"issue":"1\u20132","key":"629_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0378-5955(95)00049-A","volume":"86","author":"J Lautermann","year":"1995","unstructured":"Lautermann J, McLaren J, Schacht J. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res. 1995;86(1\u20132):15\u201324.","journal-title":"Hear Res."},{"issue":"5","key":"629_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0021-9924(98)00014-8","volume":"31","author":"S Usami","year":"1998","unstructured":"Usami S, Abe S, Shinkawa H, Kimberling WJ. Sensorineural hearing loss caused by mitochondrial DNA mutations: special reference to the A1555G mutation. J Commun Disord. 1998;31(5):423\u201334 (quiz 34\u20135).","journal-title":"J Commun Disord."},{"issue":"1","key":"629_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1086\/381133","volume":"74","author":"H Zhao","year":"2004","unstructured":"Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, et al. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet. 2004;74(1):139\u201352.","journal-title":"Am J Hum Genet."},{"issue":"11","key":"629_CR51","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/14992020802215862","volume":"47","author":"LH Bindu","year":"2008","unstructured":"Bindu LH, Reddy PP. Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review. Int J Audiol. 2008;47(11):702\u20137.","journal-title":"Int J Audiol."},{"issue":"9","key":"629_CR52","doi-asserted-by":"publisher","first-page":"e02586-16","DOI":"10.1128\/AAC.02586-16","volume":"61","author":"A Arnold","year":"2017","unstructured":"Arnold A, Cooke GS, Kon OM, Dedicoat M, Lipman M, Loyse A, et al. The adverse effects and choice of injectable agents in MDR-TB: amikacin or capreomycin. Antimicrob Agents Chemother. 2017;61(9):e02586-16.","journal-title":"Antimicrob Agents Chemother."},{"issue":"12","key":"629_CR53","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/BF01590935","volume":"14","author":"J Blaser","year":"1995","unstructured":"Blaser J, Konig C. Once-daily dosing of aminoglycosides. Eur J Clin Microbiol Infect Dis. 1995;14(12):1029\u201338.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"5","key":"629_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2796.1993.tb00691.x","volume":"233","author":"U Axdorph","year":"1993","unstructured":"Axdorph U, Laurell G, Bjorkholm M. Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin. J Intern Med. 1993;233(5):401\u20137.","journal-title":"J Intern Med."},{"key":"629_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6815-7-5","volume":"7","author":"P Duggal","year":"2007","unstructured":"Duggal P, Sarkar M. Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear Nose Throat Disord. 2007;7:5.","journal-title":"BMC Ear Nose Throat Disord."},{"issue":"2","key":"629_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/resp.12676","volume":"21","author":"CM Ellender","year":"2016","unstructured":"Ellender CM, Law DB, Thomson RM, Eather GW. Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease. Respirology. 2016;21(2):357\u201362.","journal-title":"Respirology."},{"issue":"5","key":"629_CR57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ijporl.2010.01.021","volume":"74","author":"LM Martins","year":"2010","unstructured":"Martins LM, Camargos PA, Becker HM, Becker CG, Guimaraes RE. Hearing loss in cystic fibrosis. Int J Pediatr Otorhinolaryngol. 2010;74(5):469\u201373.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"issue":"6","key":"629_CR58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3766\/jaaa.21.6.6","volume":"21","author":"MF Dille","year":"2010","unstructured":"Dille MF, Konrad-Martin D, Gallun F, Helt WJ, Gordon JS, Reavis KM, et al. Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study. J Am Acad Audiol. 2010;21(6):409\u201317.","journal-title":"J Am Acad Audiol."},{"issue":"6","key":"629_CR59","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1128\/AAC.9.6.956","volume":"9","author":"RE Black","year":"1976","unstructured":"Black RE, Lau WK, Weinstein RJ, Young LS, Hewitt WL. Ototoxicity of amikacin. Antimicrob Agents Chemother. 1976;9(6):956\u201361.","journal-title":"Antimicrob Agents Chemother."},{"issue":"1","key":"629_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1592\/phco.22.1.105.33507","volume":"22","author":"AK Saxena","year":"2002","unstructured":"Saxena AK, Panhotra BR, Naguib M. Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy. 2002;22(1):105\u20138.","journal-title":"Pharmacotherapy."},{"issue":"10","key":"629_CR61","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.1128\/AAC.01050-15","volume":"59","author":"C Modongo","year":"2015","unstructured":"Modongo C, Pasipanodya JG, Zetola NM, Williams SM, Sirugo G, Gumbo T. Amikacin concentrations predictive of ototoxicity in multidrug-resistant tuberculosis patients. Antimicrob Agents Chemother. 2015;59(10):6337\u201343.","journal-title":"Antimicrob Agents Chemother."},{"key":"629_CR62","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/1471-2334-14-542","volume":"14","author":"C Modongo","year":"2014","unstructured":"Modongo C, Sobota RS, Kesenogile B, Ncube R, Sirugo G, Williams SM, et al. Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. BMC Infect Dis. 2014;14:542.","journal-title":"BMC Infect Dis."},{"issue":"7","key":"629_CR63","first-page":"622","volume":"6","author":"P Jager de","year":"2002","unstructured":"de Jager P, van Altena R. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int J Tuberc Lung Dis. 2002;6(7):622\u20137.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"2","key":"629_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/08860220903491224","volume":"32","author":"B Tokgoz","year":"2010","unstructured":"Tokgoz B, Somdas MA, Ucar C, Kocyigit I, Unal A, Sipahioglu MH, et al. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD. Ren Fail. 2010;32(2):179\u201384.","journal-title":"Ren Fail."},{"issue":"16","key":"629_CR65","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2146\/ajhp140564","volume":"72","author":"MS Stankowicz","year":"2015","unstructured":"Stankowicz MS, Ibrahim J, Brown DL. Once-daily aminoglycoside dosing: AN update on current literature. Am J Health Syst Pharm. 2015;72(16):1357\u201364.","journal-title":"Am J Health Syst Pharm."},{"issue":"Suppl C","key":"629_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jac\/27.suppl_C.49","volume":"27","author":"PM Tulkens","year":"1991","unstructured":"Tulkens PM. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin. J Antimicrob Chemother. 1991;27(Suppl C):49\u201361.","journal-title":"J Antimicrob Chemother."},{"issue":"2","key":"629_CR67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/20786190.2014.1002220","volume":"57","author":"L Petersen","year":"2015","unstructured":"Petersen L, Rogers C. Aminoglycoside-induced hearing deficits\u2014a review of cochlear ototoxicity. S Afr Fam Pract. 2015;57(2):77\u201382.","journal-title":"S Afr Fam Pract."},{"key":"629_CR68","first-page":"3","volume":"43","author":"GR Voogt","year":"1996","unstructured":"Voogt GR, Schoeman HS. Ototoxicity of aminoglycoside drugs in tuberculosis treatment. S Afr J Commun Disord. 1996;43:3\u20136.","journal-title":"S Afr J Commun Disord."},{"issue":"86","key":"629_CR69","first-page":"203","volume":"28","author":"V Sharma","year":"2016","unstructured":"Sharma V, Bhagat S, Verma B, Singh R, Singh S. Audiological evaluation of patients taking kanamycin for multidrug resistant tuberculosis. Iran J Otorhinolaryngol. 2016;28(86):203\u20138.","journal-title":"Iran J Otorhinolaryngol."},{"issue":"3","key":"629_CR70","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00405-016-4117-z","volume":"274","author":"S Waissbluth","year":"2017","unstructured":"Waissbluth S, Peleva E, Daniel SJ. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria. Eur Arch Otorhinolaryngol. 2017;274(3):1187\u201396.","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"629_CR71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-319-13473-4_12","volume-title":"Oxidative stress in applied basic research and clinical practice: free radicals in ENT pathology","author":"JM Anderson","year":"2015","unstructured":"Anderson JM, Campbell K. Assessment of interventions to prevent drug-induced hearing loss. In: Miller JM, Le Prell CG, Rybak LP, editors. Oxidative stress in applied basic research and clinical practice: free radicals in ENT pathology. New York: Humana Press; 2015. p. 243\u201369."},{"key":"629_CR72","first-page":"141","volume-title":"Translational research in audiology and the hearing sciences, Springer handbook of auditory research","author":"KCM Campbell","year":"2016","unstructured":"Campbell KCM, Fox DJ. Cisplatin-induced hearing loss. In: Le Prell CG, Lobarinas E, Fay RR, Popper AN, editors. Translational research in audiology and the hearing sciences, Springer handbook of auditory research. New York: Springer; 2016. p. 141\u201364."},{"key":"629_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.heares.2015.03.002","volume":"325","author":"L Abbas","year":"2015","unstructured":"Abbas L, Rivolta MN. Aminoglycoside ototoxicity and hair cell ablation in the adult gerbil: a simple model to study hair cell loss and regeneration. Hear Res. 2015;325:12\u201326.","journal-title":"Hear Res."},{"issue":"6","key":"629_CR74","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/000348948909800602","volume":"98","author":"JB Nadol Jr","year":"1989","unstructured":"Nadol JB Jr, Young YS, Glynn RJ. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol. 1989;98(6):411\u20136.","journal-title":"Ann Otol Rhinol Laryngol."},{"issue":"3","key":"629_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/infdis\/156.3.449","volume":"156","author":"R Hinojosa","year":"1987","unstructured":"Hinojosa R, Lerner SA. Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. J Infect Dis. 1987;156(3):449\u201355.","journal-title":"J Infect Dis."},{"issue":"11","key":"629_CR76","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1288\/00005537-196511000-00002","volume":"75","author":"GJ Matz","year":"1965","unstructured":"Matz GJ, Wallace TH, Ward PH. The ototoxicity of kanamycin. A comparative histopathological study. Laryngoscope. 1965;75(11):1690\u20138.","journal-title":"Laryngoscope."},{"key":"629_CR77","first-page":"23","volume":"82","author":"JO Frost","year":"1960","unstructured":"Frost JO, Hawkins JE Jr, Daly JF. Kanamycin. II. Ototoxicity. Am Rev Respir Dis. 1960;82:23\u201330.","journal-title":"Am Rev Respir Dis."},{"issue":"5","key":"629_CR78","first-page":"995","volume":"59","author":"IJ Piel","year":"1975","unstructured":"Piel IJ, Perlia CP. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies. Cancer Chemother Rep. 1975;59(5):995\u20139.","journal-title":"Cancer Chemother Rep."},{"issue":"6","key":"629_CR79","first-page":"365","volume":"12","author":"MJ Moroso","year":"1983","unstructured":"Moroso MJ, Blair RL. A review of cis-platinum ototoxicity. J Otolaryngol. 1983;12(6):365\u20139.","journal-title":"J Otolaryngol."},{"issue":"1","key":"629_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00464398","volume":"242","author":"K Boheim","year":"1985","unstructured":"Boheim K, Bichler E. Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology. Arch Otorhinolaryngol. 1985;242(1):1\u20136.","journal-title":"Arch Otorhinolaryngol."},{"issue":"12","key":"629_CR81","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/S0022215100101161","volume":"100","author":"SD Comis","year":"1986","unstructured":"Comis SD, Rhys-Evans PH, Osborne MP, Pickles JO, Jeffries DJ, Pearse HA. Early morphological and chemical changes induced by cisplatin in the guinea pig organ of Corti. J Laryngol Otol. 1986;100(12):1375\u201383.","journal-title":"J Laryngol Otol."},{"issue":"8","key":"629_CR82","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0.CO;2-F","volume":"56","author":"SD Schaefer","year":"1985","unstructured":"Schaefer SD, Post JD, Close LG, Wright CG. Ototoxicity of low- and moderate-dose cisplatin. Cancer. 1985;56(8):1934\u20139.","journal-title":"Cancer."},{"key":"629_CR83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-319-13473-4_11","volume-title":"Oxidative stress in applied basic research and clinical practice: free radicals in ENT pathology","author":"G Laurell","year":"2015","unstructured":"Laurell G, Pierre PV. Hearing loss after cisplatin: oxidative stress pathways and potential for protection. In: Miller JM, Le Prell CG, Rybak LP, editors. Oxidative stress in applied basic research and clinical practice: free radicals in ENT pathology. New York: Humana Press; 2015. p. 217\u201341."},{"key":"629_CR84","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejca.2016.09.023","volume":"69","author":"E Clemens","year":"2016","unstructured":"Clemens E, de Vries AC, Pluijm SF, Am Zehnhoff-Dinnesen A, Tissing WJ, Loonen JJ, et al. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: a DCOG late-effects study. Eur J Cancer. 2016;69:77\u201385.","journal-title":"Eur J Cancer."},{"key":"629_CR85","doi-asserted-by":"publisher","DOI":"10.1080\/14992027.2017.1355570","author":"B Brooks","year":"2017","unstructured":"Brooks B, Knight K. Ototoxicity monitoring in children treated with platinum chemotherapy. Int J Audiol. 2017. https:\/\/doi.org\/10.1080\/14992027.2017.1355570 (Epub 24 Jul 2017).","journal-title":"Int J Audiol."},{"issue":"2","key":"629_CR86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/08880018.2017.1323985","volume":"34","author":"E Clemens","year":"2017","unstructured":"Clemens E, de Vries AC, Am Zehnhoff-Dinnesen A, Tissing WJ, Loonen JJ, Pluijm SF, et al. Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors. Pediatr Hematol Oncol. 2017;34(2):120\u20139.","journal-title":"Pediatr Hematol Oncol."},{"issue":"3","key":"629_CR87","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/AUD.0000000000000391","volume":"38","author":"JR DeBacker","year":"2017","unstructured":"DeBacker JR, Harrison RT, Bielefeld EC. Long-term synergistic interaction of cisplatin- and noise-induced hearing losses. Ear Hear. 2017;38(3):282\u201391.","journal-title":"Ear Hear."},{"issue":"1\u20132","key":"629_CR88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0378-5955(90)90046-R","volume":"50","author":"MA Gratton","year":"1990","unstructured":"Gratton MA, Salvi RJ, Kamen BA, Saunders SS. Interaction of cisplatin and noise on the peripheral auditory system. Hear Res. 1990;50(1\u20132):211\u201323.","journal-title":"Hear Res."},{"issue":"1","key":"629_CR89","first-page":"1","volume":"36","author":"I Ohtani","year":"1990","unstructured":"Ohtani I, Okamura H, Kobari M, Yamanobe S, Hoshino T, Yamaguchi M, et al. Potentiation of inner ear damage following electron beam irradiation with CDDP administration. Fukushima J Med Sci. 1990;36(1):1\u201310.","journal-title":"Fukushima J Med Sci."},{"issue":"1","key":"629_CR90","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/13816810.2015.1137325","volume":"38","author":"ML Geurtsen","year":"2017","unstructured":"Geurtsen ML, Kors WA, Moll AC, Smits C. Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma. Ophthalmic Genet. 2017;38(1):74\u20138.","journal-title":"Ophthalmic Genet."},{"issue":"11","key":"629_CR91","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/pbc.25618","volume":"62","author":"A Batra","year":"2015","unstructured":"Batra A, Thakar A, Bakhshi S. Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: a cross-sectional study of 116 patients. Pediatr Blood Cancer. 2015;62(11):2060.","journal-title":"Pediatr Blood Cancer."},{"issue":"6","key":"629_CR92","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","volume":"32","author":"W Landier","year":"2014","unstructured":"Landier W, Knight K, Wong FL, Lee J, Thomas O, Kim H, et al. Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales\u2013a report from the Children\u2019s Oncology Group. J Clin Oncol. 2014;32(6):527\u201334.","journal-title":"J Clin Oncol."},{"issue":"23","key":"629_CR93","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","volume":"34","author":"RD Frisina","year":"2016","unstructured":"Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016;34(23):2712\u201320.","journal-title":"J Clin Oncol."},{"issue":"9","key":"629_CR94","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s00405-015-3857-5","volume":"273","author":"R Niemensivu","year":"2016","unstructured":"Niemensivu R, Saarilahti K, Ylikoski J, Aarnisalo A, Makitie AA. Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy. Eur Arch Otorhinolaryngol. 2016;273(9):2509\u201314.","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"629_CR95","first-page":"Cd010181","volume":"8","author":"JW As van","year":"2016","unstructured":"van As JW, van den Berg H, van Dalen EC. Platinum-induced hearing loss after treatment for childhood cancer. Cochrane Database Syst Rev. 2016;8:Cd010181.","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"629_CR96","first-page":"333","volume":"30","author":"SA Fausti","year":"1993","unstructured":"Fausti SA, Frey RH, Henry JA, Olson DJ, Schaffer HI. High-frequency testing techniques and instrumentation for early detection of ototoxicity. J Rehabil Res Dev. 1993;30(3):333\u201341.","journal-title":"J Rehabil Res Dev."},{"issue":"6","key":"629_CR97","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archotol.1993.01880180081015","volume":"119","author":"SA Fausti","year":"1993","unstructured":"Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, Bagby GC Jr. High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg. 1993;119(6):661\u20136.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"issue":"3","key":"629_CR98","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00003446-199406000-00004","volume":"15","author":"SA Fausti","year":"1994","unstructured":"Fausti SA, Larson VD, Noffsinger D, Wilson RH, Phillips DS, Fowler CG. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear. 1994;15(3):232\u20139.","journal-title":"Ear Hear."},{"issue":"2","key":"629_CR99","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1672-2930(12)50023-1","volume":"7","author":"D Dalian","year":"2012","unstructured":"Dalian D, Haiyan J, Yong F, Salvi R, Someya S, Tanokura M. Ototoxic effects of carboplatin in organotypic cultures in chinchillas and rats. J Otol. 2012;7(2):92\u2013101.","journal-title":"J Otol."},{"issue":"11","key":"629_CR100","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/ar.22577","volume":"295","author":"D Ding","year":"2012","unstructured":"Ding D, Allman BL, Salvi R. Review: ototoxic characteristics of platinum antitumor drugs. Anat Rec. 2012;295(11):1851\u201367.","journal-title":"Anat Rec."},{"issue":"5","key":"629_CR101","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/00206099209072917","volume":"31","author":"M Taudy","year":"1992","unstructured":"Taudy M, Syka J, Popelar J, Ulehlova L. Carboplatin and cisplatin ototoxicity in guinea pigs. Audiology. 1992;31(5):293\u20139.","journal-title":"Audiology."},{"issue":"1","key":"629_CR102","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0385-8146(89)80003-3","volume":"16","author":"T Saito","year":"1989","unstructured":"Saito T, Saito H, Saito K, Wakui S, Manabe Y, Tsuda G. Ototoxicity of carboplatin in guinea pigs. Auris Nasus Larynx. 1989;16(1):13\u201321.","journal-title":"Auris Nasus Larynx."},{"key":"629_CR103","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2017.00338","volume":"11","author":"S Sheth","year":"2017","unstructured":"Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci. 2017;11:338\u201350.","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"629_CR104","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1345\/aph.18288","volume":"33","author":"PE Moss","year":"1999","unstructured":"Moss PE, Hickman S, Harrison BR. Ototoxicity associated with vinblastine. Ann Pharmacother. 1999;33(4):423\u20135.","journal-title":"Ann Pharmacother."},{"issue":"5","key":"629_CR105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0030-6665(20)30766-0","volume":"26","author":"VG Schweitzer","year":"1993","unstructured":"Schweitzer VG. Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am. 1993;26(5):759\u201389.","journal-title":"Otolaryngol Clin North Am."},{"issue":"3","key":"629_CR106","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1179\/joc.2003.15.3.290","volume":"15","author":"MT Kalcioglu","year":"2003","unstructured":"Kalcioglu MT, Kuku I, Kaya E, Oncel S, Aydogdu I. Bilateral hearing loss during vincristine therapy: a case report. J Chemother. 2003;15(3):290\u20132.","journal-title":"J Chemother."},{"issue":"6","key":"629_CR107","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1179\/joc.2000.12.6.530","volume":"12","author":"I Aydogdu","year":"2000","unstructured":"Aydogdu I, Ozturan O, Kuku I, Kaya E, Sevinc A, Yildiz R. Bilateral transient hearing loss associated with vincristine therapy: case report. J Chemother. 2000;12(6):530\u20132.","journal-title":"J Chemother."},{"issue":"5","key":"629_CR108","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/014556131109000506","volume":"90","author":"R Singh Chauhan","year":"2011","unstructured":"Singh Chauhan R, Saxena RK, Varshey S. The role of ultrahigh-frequency audiometry in the early detection of systemic drug-induced hearing loss. Ear Nose Throat J. 2011;90(5):218\u201322.","journal-title":"Ear Nose Throat J."},{"issue":"3","key":"629_CR109","first-page":"273","volume":"47","author":"RM Constantinescu","year":"2009","unstructured":"Constantinescu RM, Georgescu M, Pascu A, Hristea A, Arama V, Baicus C, et al. Otoacoustic emissions analysers for monitoring aminoglycosides ototoxicity. Rom J Intern Med. 2009;47(3):273\u20138.","journal-title":"Rom J Intern Med."},{"issue":"3","key":"629_CR110","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0165-5876(99)00247-5","volume":"50","author":"P Stavroulaki","year":"1999","unstructured":"Stavroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D. Otoacoustic emissions\u2013an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol. 1999;50(3):177\u201384.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"629_CR111","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1097\/MAO.0000000000001134","volume":"37","author":"D Konrad-Martin","year":"2016","unstructured":"Konrad-Martin D, Poling GL, Dreisbach LE, Reavis KM, McMillan GP, Lapsley Miller JA, et al. Serial monitoring of otoacoustic emissions in clinical trials. Otol Neurotol. 2016;37:e286\u201394.","journal-title":"Otol Neurotol."},{"key":"629_CR112","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0031-1286618","volume":"32","author":"PK Das-Purkayastha","year":"2011","unstructured":"Das-Purkayastha PK, Rutka JA. How should awareness of ototoxicity change the way medicine is practiced? Semin Hearing. 2011;32:236\u201347.","journal-title":"Semin Hearing."},{"key":"629_CR113","unstructured":"American Academy of Audiology. Position statement and clinical practice guidelines: Ototoxicity monitoring. 2009. http:\/\/audiology-web.s3.amazonaws.com\/migrated\/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf . Accessed 1 Oct 2017."},{"issue":"Suppl. 12","key":"629_CR114","first-page":"11","volume":"36","author":"American Speech-Language-Hearing Association","year":"1994","unstructured":"American Speech-Language-Hearing Association. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA. 1994;36(Suppl. 12):11\u20139.","journal-title":"ASHA"},{"key":"629_CR115","volume-title":"Pharmacology and ototoxicity for audiologists","author":"SA Fausti","year":"2007","unstructured":"Fausti SA, Helt WJ, Gordon JS, Reavis KM, Phillips DS, Konrad-Martin DL. Audiologic monitoring for ototoxicity and patient management. In: Campbell KCM, editor. Pharmacology and ototoxicity for audiologists. Clifton Park: Thomson Delmar Learning; 2007."},{"key":"629_CR116","first-page":"138","volume-title":"Pharmacology and ototoxicity for audiologists","author":"LP Rybak","year":"2007","unstructured":"Rybak LP, Huang X, Campbell KC. Cancer and ototoxicity of chemotherapeutics. In: Campbell KCM, editor. Pharmacology and ototoxicity for audiologists. Clifton Park: Thomson Delmar Learning; 2007. p. 138\u201362."},{"issue":"8","key":"629_CR117","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/sj.ki.5002434","volume":"72","author":"LP Rybak","year":"2007","unstructured":"Rybak LP, Ramkumar V. Ototoxicity. Kidney International. 2007;72(8):931\u20135.","journal-title":"Kidney International."},{"issue":"5","key":"629_CR118","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0030-6665(20)30774-X","volume":"26","author":"KCM Campbell","year":"1993","unstructured":"Campbell KCM, Durrant J. Audiologic monitoring for ototoxicity. Otolaryngol Clin N Am. 1993;26(5):903\u20139.","journal-title":"Otolaryngol Clin N Am."},{"key":"629_CR119","first-page":"153","volume-title":"ototoxicity","author":"KCM Campbell","year":"2004","unstructured":"Campbell KCM. Audiologic monitoring for ototoxicity. In: Roland P, Rutkas J, editors. ototoxicity. Hamilton: BC Decker; 2004. p. 153\u201360."},{"issue":"4","key":"629_CR120","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/archotol.1990.01870040046011","volume":"116","author":"GP Jacobson","year":"1990","unstructured":"Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990;116(4):424\u20137.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"issue":"5","key":"629_CR121","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00003446-199110000-00009","volume":"12","author":"CW Newman","year":"1991","unstructured":"Newman CW, Weinstein BE, Jacobson GP, Hug GA. Test-retest reliability of the hearing handicap inventory for adults. Ear Hear. 1991;12(5):355\u20137.","journal-title":"Ear Hear."},{"key":"629_CR122","first-page":"153","volume":"9","author":"CW Newman","year":"1998","unstructured":"Newman CW, Sandridge SA, Jacobson GP. Psychometric adaquacy of the tinnitus handicap inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998;9:153\u201360.","journal-title":"J Am Acad Audiol."},{"issue":"9","key":"629_CR123","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3766\/jaaa.24.9.2","volume":"24","author":"MF Dille","year":"2013","unstructured":"Dille MF, Ellingson RM, McMillan GP, Konrad-Martin D. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring. J Am Acad Audiol. 2013;24(9):769\u201381.","journal-title":"J Am Acad Audiol."},{"key":"629_CR124","first-page":"197","volume-title":"Pharmacology and ototoxicity for audiologists","author":"B Pouyatos","year":"2007","unstructured":"Pouyatos B, Fechter LD. Industrial chemicals affecting the auditory system. In: Campbell KCM, editor. Pharmacology and ototoxicity for audiologists. Clifton Park: Thomson Delmar Learning; 2007. p. 197\u2013215."},{"issue":"1\u20132","key":"629_CR125","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0378-5955(96)00152-9","volume":"102","author":"KC Campbell","year":"1996","unstructured":"Campbell KC, Rybak LP, Meech RP, Hughes L. D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res. 1996;102(1\u20132):90\u20138.","journal-title":"Hear Res."},{"issue":"5","key":"629_CR126","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/14992027.2016.1143980","volume":"55","author":"KC Campbell","year":"2016","unstructured":"Campbell KC, Martin SM, Meech RP, Hargrove TL, Verhulst SJ, Fox DJ. D-methionine (D-met) significantly reduces kanamycin-induced ototoxicity in pigmented guinea pigs. Int J Audiol. 2016;55(5):273\u20138.","journal-title":"Int J Audiol."},{"issue":"2","key":"629_CR127","first-page":"94","volume":"13","author":"S Aksoy","year":"2007","unstructured":"Aksoy S, Firat Y, Alpar R. The Tinnitus Handicap Inventory: a study of validity and reliability. Int Tinnitus J. 2007;13(2):94\u20138.","journal-title":"Int Tinnitus J."},{"issue":"11","key":"629_CR128","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1258\/0022215001904392","volume":"114","author":"DM Baguley","year":"2000","unstructured":"Baguley DM, Humphriss RL, Hodgson CA. Convergent validity of the tinnitus handicap inventory and the tinnitus questionnaire. J Laryngol Otol. 2000;114(11):840\u20133.","journal-title":"J Laryngol Otol."},{"issue":"7","key":"629_CR129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0042-1745622","volume":"12","author":"D Baguley","year":"2001","unstructured":"Baguley D, Norman M. Tinnitus handicap inventory. J Am Acad Audiol. 2001;12(7):379\u201380.","journal-title":"J Am Acad Audiol."},{"issue":"1","key":"629_CR130","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1044\/1059-0889(2003\/007)","volume":"12","author":"DM Baguley","year":"2003","unstructured":"Baguley DM, Andersson G. Factor analysis of the Tinnitus Handicap Inventory. Am J Audiol. 2003;12(1):31\u20134.","journal-title":"Am J Audiol."},{"issue":"9","key":"629_CR131","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/14992027.2011.653448","volume":"51","author":"US Bankstahl","year":"2012","unstructured":"Bankstahl US, Elkin EP, Gebauer A, Gortelmeyer R. Validation of the THI-12 questionnaire for international use in assessing tinnitus: a multi-centre, prospective, observational study. Int J Audiol. 2012;51(9):671\u20137.","journal-title":"Int J Audiol."},{"issue":"1","key":"629_CR132","first-page":"E183","volume":"20","author":"K Campbell","year":"2017","unstructured":"Campbell K, Kutz JW Jr, Shoup A, Wen W, Lynch SY, He E, et al. Evaluation of the ototoxicity potential of once-daily, single-entity hydrocodone in patients with chronic pain: Results of two Phase-3 clinical studies. Pain physician. 2017;20(1):E183\u201393.","journal-title":"Pain physician."},{"key":"629_CR133","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/ijpvm.IJPVM_229_17","volume":"8","author":"SH Abtahi","year":"2017","unstructured":"Abtahi SH, Hashemi SM, Mahmoodi M, Nilforoush MH. Comparison of melatonin and sertraline therapies on tinnitus: a randomized clinical trial. Int J Prev Med. 2017;8:61.","journal-title":"Int J Prev Med."},{"issue":"3","key":"629_CR134","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bjorl.2015.04.016","volume":"82","author":"JF Polanski","year":"2016","unstructured":"Polanski JF, Soares AD, de Mendonca Cruz OL. Antioxidant therapy in the elderly with tinnitus. Braz J Otorhinolaryngol. 2016;82(3):269\u201374.","journal-title":"Braz J Otorhinolaryngol."},{"issue":"2","key":"629_CR135","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/00016489.2013.844854","volume":"134","author":"SK Lee","year":"2014","unstructured":"Lee SK, Chung H, Chung JH, Yeo SG, Park MS, Byun JY. Effectiveness of transcutaneous electrical stimulation for chronic tinnitus. Acta Otolaryngol. 2014;134(2):159\u201367.","journal-title":"Acta Otolaryngol."},{"issue":"2","key":"629_CR136","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/AUD.0b013e31822f67c0","volume":"33","author":"MB Meikle","year":"2012","unstructured":"Meikle MB, Henry JA, Griest SE, Stewart BJ, Abrams HB, McArdle R, et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear. 2012;33(2):153\u201376.","journal-title":"Ear Hear."},{"key":"629_CR137","doi-asserted-by":"publisher","DOI":"10.1097\/aud.0000000000000505","author":"EW Beukes","year":"2017","unstructured":"Beukes EW, Baguley DM, Allen PM, Manchaiah V, Andersson G. Audiologist-guided internet-based cognitive behavior therapy for adults with tinnitus in the United Kingdom: a randomized controlled trial. Ear Hear. 2017. https:\/\/doi.org\/10.1097\/aud.0000000000000505 (Epub 1 Nov 2017).","journal-title":"Ear Hear."},{"issue":"6","key":"629_CR138","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3766\/jaaa.16067","volume":"28","author":"JA Henry","year":"2017","unstructured":"Henry JA, McMillan G, Dann S, Bennett K, Griest S, Theodoroff S, et al. Tinnitus management: Randomized controlled trial comparing extended-wear hearing aids, conventional hearing aids, and combination instruments. J Am Acad Audiol. 2017;28(6):546\u201361.","journal-title":"J Am Acad Audiol."},{"issue":"4","key":"629_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1044\/2017_AJA-17-0022","volume":"26","author":"SM Theodoroff","year":"2017","unstructured":"Theodoroff SM, McMillan GP, Zaugg TL, Cheslock M, Roberts C, Henry JA. Randomized controlled trial of a novel device for tinnitus sound therapy during sleep. Am J Audiol. 2017;26(4):1\u201312.","journal-title":"Am J Audiol"},{"issue":"4","key":"629_CR140","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/lio2.76","volume":"2","author":"CA Bauer","year":"2017","unstructured":"Bauer CA, Berry JL, Brozoski TJ. The effect of tinnitus retraining therapy on chronic tinnitus: a controlled trial. Laryngoscope Investig Otolaryngol. 2017;2(4):166\u201377.","journal-title":"Laryngoscope Investig Otolaryngol."},{"key":"629_CR141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3766\/jaaa.14.3.2","volume":"14","author":"KCM Campbell","year":"2003","unstructured":"Campbell KCM, Kelly E, Targovnik N, Hughes LH, Van Saders C, Gottlieb AB, et al. Audiologic monitoring for potential ototoxicity in a phase I clinical trial of a new glycopeptide antibiotic. J Am Acad Audiol. 2003;14:157\u201368.","journal-title":"J Am Acad Audiol."},{"key":"629_CR142","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1044\/jshd.2404.330","volume":"24","author":"R Carhart","year":"1959","unstructured":"Carhart R, Jerger J. Preferred method for clinical determination of pure-tone thresholds. J Speech Hear Res. 1959;24:330\u201345.","journal-title":"J Speech Hear Res."},{"issue":"4","key":"629_CR143","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/01050398009076360","volume":"9","author":"D Osterhammel","year":"1980","unstructured":"Osterhammel D. High frequency audiometry. Clinical aspects. Scand Audiol. 1980;9(4):249\u201356.","journal-title":"Clinical aspects. Scand Audiol."},{"issue":"3","key":"629_CR144","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0090-8258(89)90519-2","volume":"33","author":"E Kujansuu","year":"1989","unstructured":"Kujansuu E, Rahko T, Punnonen R, Karma P. Evaluation of the hearing loss associated with cis-platinum treatment by high-frequency audiometry. Gynecol Oncol. 1989;33(3):321\u20132.","journal-title":"Gynecol Oncol."},{"issue":"4","key":"629_CR145","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1121\/1.398698","volume":"86","author":"PG Stelmachowicz","year":"1989","unstructured":"Stelmachowicz PG, Beauchaine KA, Kalberer A, Jesteadt W. Normative thresholds in the 8- to 20-kHz range as a function of age. J Acoust Soc Am. 1989;86(4):1384\u201391.","journal-title":"J Acoust Soc Am."},{"issue":"5","key":"629_CR146","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1044\/jslhr.4105.1061","volume":"41","author":"TL Wiley","year":"1998","unstructured":"Wiley TL, Cruickshanks KJ, Nondahl DM, Tweed TS, Klein R, Klein R, et al. Aging and high-frequency hearing sensitivity. J Speech Lang Hear Res. 1998;41(5):1061\u201372.","journal-title":"J Speech Lang Hear Res."},{"issue":"4","key":"629_CR147","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0028-1092011","volume":"6","author":"JL Northern","year":"1985","unstructured":"Northern JL, Ratkiewicz B. The quest for high-frequency normative data. Semin Hear. 1985;6(4):331\u20138.","journal-title":"Semin Hear."},{"key":"629_CR148","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/s-0028-1092013","volume":"6","author":"SA Fausti","year":"1985","unstructured":"Fausti SA, Frey RH, Rappaport BZ, Schechter MA. High-frequency audiometry with an earphone transducer. Semin Hear. 1985;6:347\u201357.","journal-title":"Semin Hear."},{"issue":"6","key":"629_CR149","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/00206098509078358","volume":"24","author":"WA Dreschler","year":"1985","unstructured":"Dreschler WA, vd Hulst RJ, Tange RA, Urbanus NA. The role of high-frequency audiometry in early detection of ototoxicity. Audiology. 1985;24(6):387\u201395.","journal-title":"Audiology."},{"issue":"8","key":"629_CR150","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1288\/00005537-199108000-00005","volume":"101","author":"JG Feghali","year":"1991","unstructured":"Feghali JG, Bernstein RS. A new approach to serial monitoring of ultra-high frequency hearing. Laryngoscope. 1991;101(8):825\u20139.","journal-title":"Laryngoscope."},{"issue":"6","key":"629_CR151","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00003446-199012000-00007","volume":"11","author":"T Frank","year":"1990","unstructured":"Frank T. High-frequency hearing thresholds in young adults using a commercially available audiometer. Ear Hear. 1990;11(6):450\u20134.","journal-title":"Ear Hear."},{"issue":"4","key":"629_CR152","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/00003446-199108000-00009","volume":"12","author":"T Frank","year":"1991","unstructured":"Frank T, Dreisbach LE. Repeatability of high-frequency thresholds. Ear Hear. 1991;12(4):294\u20135.","journal-title":"Ear Hear."},{"issue":"2","key":"629_CR153","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00003446-200104000-00009","volume":"22","author":"T Frank","year":"2001","unstructured":"Frank T. High frequency (8 to 16\u00a0kHz) reference thresholds and intrasubject threshold variability relative to ototoxicity criteria using a sennheiser HAD 200 earphone. Ear Hear. 2001;22(2):161\u20138.","journal-title":"Ear Hear."},{"issue":"9","key":"629_CR154","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-2007-998077","volume":"70","author":"PK Plinkert","year":"1991","unstructured":"Plinkert PK, Krober S. Early detection of cisplatin-induced ototoxicity using evoked otoacoustic emissions [in German]. Laryngorhinootologie. 1991;70(9):457\u201362.","journal-title":"Laryngorhinootologie."},{"issue":"4","key":"629_CR155","first-page":"123","volume":"40","author":"A Beck","year":"1992","unstructured":"Beck A, Maurer J, Welkoborsky HJ, Mann W. Changes in transitory evoked otoacoustic emissions in chemotherapy with cisplatin and 5FU [in German]. HNO. 1992;40(4):123\u20137.","journal-title":"HNO."},{"issue":"1\u20133","key":"629_CR156","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0165-5876(93)90011-Q","volume":"25","author":"PG Zorowka","year":"1993","unstructured":"Zorowka PG, Schmitt HJ, Gutjahr P. Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy. Int J Pediatr Otorhinolaryngol. 1993;25(1\u20133):73\u201380.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"issue":"1","key":"629_CR157","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/03005364000000004","volume":"31","author":"M Mulheran","year":"1997","unstructured":"Mulheran M, Degg C. Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects. Br J Audiol. 1997;31(1):5\u20139.","journal-title":"Br J Audiol."},{"issue":"6","key":"629_CR158","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/hn.1999.v121.a101567","volume":"121","author":"BD Ress","year":"1999","unstructured":"Ress BD, Sridhar KS, Balkany TJ, Waxman GM, Stagner BB, Lonsbury-Martin BL. Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place\u2014Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg. 1999;121(6):693\u2013701.","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"4","key":"629_CR159","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-2001-19111","volume":"22","author":"BL Lonsbury-Martin","year":"2001","unstructured":"Lonsbury-Martin BL, Martin GK. Evoked otoacoustic emissions as objective screeners for ototoxicity. Semin Hearing. 2001;22(4):377\u201391.","journal-title":"Semin Hearing."},{"issue":"34","key":"629_CR160","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"KR Knight","year":"2005","unstructured":"Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23(34):8588\u201396.","journal-title":"J Clin Oncol."},{"issue":"10","key":"629_CR161","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","volume":"25","author":"KR Knight","year":"2007","unstructured":"Knight KR, Kraemer DF, Winter C, Neuwelt EA. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol. 2007;25(10):1190\u20135.","journal-title":"J Clin Oncol."},{"key":"629_CR162","doi-asserted-by":"publisher","DOI":"10.1097\/aud.0000000000000465","author":"L Dreisbach","year":"2017","unstructured":"Dreisbach L, Zettner E, Chang Liu M, Meuel Fernhoff C, MacPhee I, Boothroyd A. High-frequency distortion-product otoacoustic emission repeatability in a patient population. Ear Hear. 2017. https:\/\/doi.org\/10.1097\/aud.0000000000000465 (Epub 1 Jul 2017).","journal-title":"Ear Hear."},{"issue":"6","key":"629_CR163","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","volume":"20","author":"SA Fausti","year":"1999","unstructured":"Fausti SA, Henry JA, Helt WJ, Phillips DS, Frey RH, Noffsinger D, et al. An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear. 1999;20(6):497\u2013505.","journal-title":"Ear Hear."},{"issue":"4","key":"629_CR164","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mpo.2950190415","volume":"19","author":"PR Brock","year":"1991","unstructured":"Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol. 1991;19(4):295\u2013300.","journal-title":"Med Pediatr Oncol."},{"issue":"5","key":"629_CR165","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/mpo.2950160517","volume":"16","author":"P Brock","year":"1988","unstructured":"Brock P, Pritchard J, Bellman S, Pinkerton CR. Ototoxicity of high-dose cis-platinum in children. Med Pediatr Oncol. 1988;16(5):368\u20139.","journal-title":"Med Pediatr Oncol."},{"issue":"10","key":"629_CR166","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1200\/JCO.2009.24.4228","volume":"28","author":"KW Chang","year":"2010","unstructured":"Chang KW, Chinosornvatana N. Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol. 2010;28(10):1788\u201395.","journal-title":"J Clin Oncol."},{"issue":"2","key":"629_CR167","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","volume":"55","author":"G Crundwell","year":"2016","unstructured":"Crundwell G, Gomersall P, Baguley DM. Ototoxicity (cochleotoxicity) classifications: a review. Int J Audiol. 2016;55(2):65\u201374.","journal-title":"Int J Audiol."},{"issue":"6","key":"629_CR168","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00003446-199012000-00004","volume":"11","author":"CW Newman","year":"1990","unstructured":"Newman CW, Weinstein BE, Jacobson GP, Hug GA. The Hearing Handicap Inventory for adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11(6):430\u20133.","journal-title":"Ear Hear."},{"issue":"3","key":"629_CR169","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00003446-198205000-00006","volume":"3","author":"IM Ventry","year":"1982","unstructured":"Ventry IM, Weinstein BE. The hearing handicap inventory for the elderly: a new tool. Ear Hear. 1982;3(3):128\u201334.","journal-title":"Ear Hear."},{"issue":"1","key":"629_CR170","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13063-016-1399-9","volume":"17","author":"DA Hall","year":"2016","unstructured":"Hall DA, Haider H, Szczepek AJ, Lau P, Rabau S, Jones-Diette J, et al. Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults. Trials. 2016;17(1):270.","journal-title":"Trials."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0629-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0629-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0629-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:10:01Z","timestamp":1719792601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0629-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":170,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0629-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"6 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kathleen Campbell is a Distinguished Scholar and Professor at Southern Illinois University School of Medicine, Springfield, IL, USA. In that capacity, she has had grants from multiple funding sources, including the National Institutes of Health and the US Department of Defense, for her research on ototoxicity and noise-induced hearing loss. In addition, she serves as a grant reviewer for those agencies. She also has served as, and continues to serve as, an ototoxicity\/audiology consultant for various Pharmaceutical Companies. She is a shareholder in AudiaCare and is the inventor on patents for D-methionine as an otoprotective agent. She receives royalties for her textbookPharmacology and Ototoxicity for Audiologists, and occasionally receives honoraria for her lectures at professional associations. Colleen Le Prell is the Emily and Phil Schepps Distinguished Professor of Hearing Science at the University of Texas, Dallas, TX, USA, where she also serves as Head of the AuD program. She has had grants from multiple funding sources, including the National Institutes of Health and the US Department of Defense, for her research on noise-induced hearing loss. She has served as an ad hoc grant reviewer for those agencies, and is currently serving on the Safety and Occupational Health study section for the National Institute of Occupational Safety and Health. She has also supervised industry contracts, supported by pharmaceutical companies, including Sound Pharmaceuticals, Edison Pharmaceuticals, and Hearing Health Science, and is an inventor on patents owned by the University of Michigan and University of Florida. She receives royalties for her bookNoise-Induced Hearing Loss: Scientific Advancesand occasionally receives honoraria for her lectures at professional associations. Both authors have no other potential conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}